- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer as a Metabolic Disorder
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 3, Pages 1155
Publisher
MDPI AG
Online
2022-01-21
DOI
10.3390/ijms23031155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer
- (2021) Jones Gyamfi et al. npj Breast Cancer
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
- (2020) Lisa M. Butler et al. ADVANCED DRUG DELIVERY REVIEWS
- Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma
- (2020) Fangming Liu et al. Journal for ImmunoTherapy of Cancer
- Mechanisms of Cancer Resistance to Immunotherapy
- (2020) Rilan Bai et al. Frontiers in Oncology
- Fatty Acid Synthase: An Emerging Target in Cancer
- (2020) Chee Wai Fhu et al. MOLECULES
- Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring
- (2020) Mariafrancesca Scalise et al. Cells
- Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
- (2020) Linyuan Xue et al. Frontiers in Oncology
- Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
- (2020) Zhefang Wang et al. Frontiers in Oncology
- Cancer survival data emphasise importance of early diagnosis
- (2019) Nigel Hawkes BMJ-British Medical Journal
- Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization
- (2019) Lisha Xiang et al. Cell Death & Disease
- Starve Cancer Cells of Glutamine: Break the Spell or Make a Hungry Monster?
- (2019) Jie Jiang et al. Cancers
- Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner
- (2019) Reika Shiratori et al. Scientific Reports
- Whole genome sequencing analysis for cancer genomics and precision medicine
- (2018) Hidewaki Nakagawa et al. CANCER SCIENCE
- An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
- (2018) Ming Chen et al. NATURE GENETICS
- Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?
- (2018) Ana-Maria Enciu et al. Biomed Research International
- Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses
- (2018) Bo Ruem Yoon et al. Frontiers in Immunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Fatty acid oxidation: An emerging facet of metabolic transformation in cancer
- (2018) Yibao Ma et al. CANCER LETTERS
- Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions
- (2018) Xi Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells
- (2018) Meng-Chi Yen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review)
- (2018) Xiang‑Hua Yu et al. Molecular Medicine Reports
- Erratum: Cancer metabolism: a therapeutic perspective
- (2017) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Lipid desaturation - the next step in targeting lipogenesis in cancer?
- (2016) Barrie Peck et al. FEBS Journal
- Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
- (2016) JIANGMAN DUAN et al. Molecular Medicine Reports
- Targeting metastasis-initiating cells through the fatty acid receptor CD36
- (2016) Gloria Pascual et al. NATURE
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- TP53 mutations, expression and interaction networks in human cancers
- (2016) Xiaosheng Wang et al. Oncotarget
- SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer
- (2016) Xiangyan Li et al. Oncotarget
- Amino Acid Transporters in Cancer and Their Relevance to "Glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs
- (2015) Y. D. Bhutia et al. CANCER RESEARCH
- Sequential cancer mutations in cultured human intestinal stem cells
- (2015) Jarno Drost et al. NATURE
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
- (2015) Chunxia Li et al. World Journal of Surgical Oncology
- Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations
- (2015) Xiangyan Li et al. Oncotarget
- Is Cancer a Genetic Disease or a Metabolic Disease?
- (2015) David S. Wishart EBioMedicine
- Structure-Function of CD36 and Importance of Fatty Acid Signal Transduction in Fat Metabolism
- (2014) Marta Yanina Pepino et al. Annual Review of Nutrition
- The mTORC1/S6K1 Pathway Regulates Glutamine Metabolism through the eIF4B-Dependent Control of c-Myc Translation
- (2014) Alfredo Csibi et al. CURRENT BIOLOGY
- Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells
- (2014) Junqin Li et al. International Journal of Biological Sciences
- Up-Regulated FASN Expression Promotes Transcoelomic Metastasis of Ovarian Cancer Cell through Epithelial-Mesenchymal Transition
- (2014) Li Jiang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health
- (2014) Lorena Pochini et al. Frontiers in Chemistry
- Cancer as a metabolic disease: implications for novel therapeutics
- (2013) T. N. Seyfried et al. CARCINOGENESIS
- Cellular Fatty Acid Metabolism and Cancer
- (2013) Erin Currie et al. Cell Metabolism
- Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
- (2013) F. Baenke et al. Disease Models & Mechanisms
- Therapeutic strategies impacting cancer cell glutamine metabolism
- (2013) Michael J Lukey et al. Future Medicinal Chemistry
- Oncometabolites: linking altered metabolism with cancer
- (2013) Ming Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- SLC27 fatty acid transport proteins
- (2013) Courtney M. Anderson et al. MOLECULAR ASPECTS OF MEDICINE
- Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia
- (2013) J. Fan et al. Molecular Systems Biology
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products
- (2012) James R. Krycer et al. BIOCHEMICAL JOURNAL
- Cancer metabolism: Key players in metabolic reprogramming
- (2012) Tomoyoshi Soga CANCER SCIENCE
- The Genetic Basis for Cancer Treatment Decisions
- (2012) Janet E. Dancey et al. CELL
- Lipid metabolism in cancer
- (2012) Claudio R. Santos et al. FEBS Journal
- Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma
- (2012) CHI-YOUNG JEONG et al. ONCOLOGY REPORTS
- The emerging role of fumarate as an oncometabolite
- (2012) Ming Yang et al. Frontiers in Oncology
- Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer
- (2011) Rong-Zong Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger?
- (2011) Anne P.L. Jensen-Urstad et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
- (2011) Rasheduzzaman Chowdhury et al. EMBO REPORTS
- Glutamine: pleiotropic roles in tumor growth and stress resistance
- (2011) Naval P. Shanware et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
- (2011) W.-C. Huang et al. MOLECULAR CANCER RESEARCH
- Identification of additional IDH mutations associated with oncometabolite R(−)-2-hydroxyglutarate production
- (2011) P S Ward et al. ONCOGENE
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer Metabolism: Is Glutamine Sweeter than Glucose?
- (2010) Weiqin Lu et al. CANCER CELL
- Glucose metabolism in cancer cells
- (2010) Alessandro Annibaldi et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
- (2010) Stefan Gross et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The mutation spectrum revealed by paired genome sequences from a lung cancer patient
- (2010) William Lee et al. NATURE
- Cancer as a metabolic disease
- (2010) Thomas N Seyfried et al. Nutrition & Metabolism
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- Quantitative techniques in 18FDG PET scanning in oncology
- (2008) F Castell et al. BRITISH JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More